Industry News
New Hope In The Fight Against Childhood Cancer
Jul 12, 2013
Cancer Research UK scientists at the University of Southampton are seeing positive results in a pre-clinical trial that could bring treatments for a particular aggressive form of childhood cancer closer to reality. Researchers in the Antibody and Vaccine Group have developed two monoclonal antibodies (mAbs) called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4... Read More
Radioimmunotherapy Deemed Safe And Effective For Lymphoma Patients
Jul 12, 2013
A new treatment option for patients with relapsing follicular, mantle cell and other indolent B-cell lymphomas has been determined safe and feasible by researchers exploring the potential of a low energy beta-emitter radiopharmaceutical... Read More
Excess Stomach Fat Can Elevate Heart Disease, Cancer Risk
Jul 12, 2013
Individuals with excessive abdominal fat have a greater risk of heart disease and cancer than individuals with a similar body mass index (BMI) who carry their fat in other areas of the body, according to a study published online in the Journal of the American College of Cardiology. Death and disease risk associated with excess body weight can vary among individuals with similar BMI... Read More
Treatment Delay In Breast Cancer Influenced By Race
Jul 12, 2013
Different factors influence delay between diagnosis and first course of treatment for breast cancer for African-American and White women. The study used data from the Carolina Breast Cancer Study (CBCS) Phase III, a program of UNC Lineberger Comprehensive Cancer Center... Read More
Potential Blood Test for Heart Disease Discovered
Jul 12, 2013
Every 40 seconds, someone in the US dies of cardiovascular disease (CVD). It is the number one cause of death in the world, but researchers from the University of Nebraska Medical Center (UNMC) may have stumbled upon an easy way to predict - and maybe prevent - deaths from this common disease. Dr... Read More
"Revlimid" A Step Closer To Being Approved For New Cases Of Multiple Myeloma
Jul 12, 2013
Celgene Corp's cancer drug Revlimid (lenalidomide) met its main goal in the drug's phase III late-stage trial, meaning that the medication is one step closer to being approved for new cases of multiple myeloma. Multiple myeloma is also known as plasma cell myeloma. It is a form of cancer that affects the plasma cells - white blood cells found in the bone marrow... Read More
Skin Cancer: One Tumor Surprisingly More Deadly Than Multiple Melanomas
Jul 12, 2013
In a study published online by the Journal of the American Medical Association (JAMA), Dr. Berwick and her team from the University of New Mexico Cancer Center discovered that patients with multiple melanoma tumors have a better chance of survival than those with only one... Read More
Study Of Dogs With Microchimerism Should Improve Understanding Of Disease In Humans
Jul 12, 2013
Some people possess a small number of cells in their bodies that are not genetically their own; this condition is known as microchimerism. It is difficult to determine potential health effects from this condition because of humans' relatively long life-spans. Now, researchers at the University of Missouri have found that microchimerism can be found in dogs as well... Read More
More Direct Control Offered By Robotic Ultrasound During Kidney Cancer Surgery
Jul 12, 2013
While the use of ultrasound to identify tumors during kidney cancer surgery is gaining acceptance, a research team at Henry Ford Hospital has successfully taken it a step further by showing an added benefit when the procedure is done robotically... Read More
Research Team Stumbles Upon Potential Blood Test for Heart Disease
Jul 12, 2013
Every 40 seconds, someone in the US dies of cardiovascular disease (CVD). It is the number one cause of death in the world, but researchers from the University of Nebraska Medical Center (UNMC) may have stumbled upon an easy way to predict - and maybe prevent - deaths from this common disease. Dr... Read More
Previous Page Next Page